Syncona Limited 2017 Dividend Scrip Reference Price
01 August 2017 - 1:39AM
UK Regulatory
TIDMSYNC
31 July 2017
Syncona Limited
2017 dividend scrip reference price
The Board of Syncona Limited (the "Company") announces that the scrip reference
price for the Company's 2017 dividend will be GBP1.7184. This is the higher of
(i) the prevailing average of the middle market quotations of the Shares
derived from the Daily Official List of the London Stock Exchange for the
ex-dividend date, 20 July 2017, and the four subsequent dealing days and (ii)
the net asset value per Share of the Company as at 30 June 2017.
[ENDS]
Enquiries
Northern Trust International Fund Administration Services (Guernsey) Limited
Company Secretary
Tel: 01481 745001
Copies of this announcement and other corporate information can be found on the
company website at:www.synconaltd.com
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on investing in and
building global leaders in life science. Our vision is to deliver
transformational treatments to patients in truly innovative areas of healthcare
while generating superior returns for shareholders. Our current investment
portfolio consists of seven high quality companies in life science and a
leading range of fund investments.
We seek to partner with the best, brightest and most ambitious minds in science
to build globally competitive businesses. We are established leaders in gene
therapy, cell therapy and advanced diagnostics, and focus on delivering
dramatic efficacy for patients in areas of high unmet need.
Our market leading funds portfolio seeks to generate superior returns by
investing in long only and alternative investment funds. This represents a
productively deployed evergreen funding base which enables us to take a long
term approach to investing in life sciences as we target the best new
opportunities and support our existing portfolio companies to grow and succeed.
Syncona is aligned with two of the premium charitable funders in UK science,
the Wellcome Trust, original founder of Syncona, and Cancer Research UK, both
of which are significant shareholders in our business. We make a donation of
0.3% of Net Asset Value to a range of charities each year.
END
(END) Dow Jones Newswires
July 31, 2017 11:39 ET (15:39 GMT)
Syncona (LSE:SYNC)
Historical Stock Chart
From Apr 2024 to May 2024
Syncona (LSE:SYNC)
Historical Stock Chart
From May 2023 to May 2024